跳到正文
原文
Nature 健康护理主题·· 2026-10-19AI 评分52

强化学习用于难治性抑郁症重复经颅磁刺激方案选择的研究

Reinforcement learning for repetitive transcranial magnetic stimulation protocol selection in treatment-resistant depression

AI 导读

本研究探索强化学习算法是否能基于常规临床数据推荐与症状改善相关的单次rTMS方案。利用1609名成人2023年1月至2025年6月在19个诊所组接受rTMS治疗的电子健康记录数据,在370名预留诊所患者中,与算法推荐相符的治疗决策关联着下一次PHQ-9评分改善增加0.788分(95% CI: 0.634–0.940)。

正文

npj Digital Medicine (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Repetitive transcranial magnetic stimulation (rTMS), including intermittent theta-burst stimulation (iTBS), is an established treatment for treatment-resistant depression, but clinicians lack evidence-based guidance for session-level choices among stimulation type, intensity, and laterality. In this study, we investigated whether a reinforcement learning (RL) algorithm trained on routine clinical data could recommend session-level rTMS protocols associated with greater symptom improvement using electronic health record data from 1609 adults treated with rTMS between January 2023 and June 2025 across 19 clinic groups. Among 370 patients from held-out clinics, treatment decisions matching algorithm recommendations were associated with 0.788 points greater next-session Patient Health Questionnaire-9 improvement than treatments that differed (95% CI: 0.634–0.940). Following every recommendation was projected to produce 3.22 points of additional improvement (95% CI: 2.72–3.75). These findings suggest RL can find treatment patterns associated with greater next-session improvement and potentially meaningful improvement accumulated across a treatment episode.

Funding

This work was supported by the National Institute on Drug Abuse under award 1K01DA061975 and the National Institute of Mental Health under award 1UG3MH141096-01. The funders had no role in study design, analysis, or the decision to submit.

Author information

Author notes

  1. These authors jointly supervised this work: Stanley Lyndon, Philip S. Wang.

Authors and Affiliations

  1. Division of Pharmacoepidemiology & Pharmacoeconomics, Mass General Brigham, Harvard Medical School, Boston, MA, USA

    Jason B. Gibbons, Loreen Straub, Jie Yang, Meekang Sung, Richard Wyss & Philip S. Wang

  2. Department of Statistics, Harvard University, Cambridge, MA, USA

    Nicolas Leenaerts & Susan A. Murphy

  3. Department of Psychiatry, Mass General Brigham, Harvard Medical School, Boston, MA, USA

    Shan H. Siddiqi, David B. Hathaway & Stanley Lyndon

  4. Department of Computer Science, Harvard University, Cambridge, MA, USA

    Susan A. Murphy

  5. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA

    Alejandro G. Szmulewicz

  6. Department of Psychiatry, Cambridge Health Alliance, Cambridge, MA, USA

    Rajendra Aldis

  7. Department of Health Policy, Harvard Medical School, Boston, MA, USA

    Jacob C. Jameson

  8. Discovery Behavioral Health, Irvine, CA, USA

    Rachel Wood, Matthew Ruble, Cason Elliott & Denise H. Mulcahy

Authors

  1. Jason B. Gibbons
  2. Nicolas Leenaerts
  3. Shan H. Siddiqi
  4. Susan A. Murphy
  5. Loreen Straub
  6. David B. Hathaway
  7. Jie Yang
  8. Alejandro G. Szmulewicz
  9. Meekang Sung
  10. Rajendra Aldis
  11. Jacob C. Jameson
  12. Richard Wyss
  13. Rachel Wood
  14. Matthew Ruble
  15. Cason Elliott
  16. Denise H. Mulcahy
  17. Stanley Lyndon
  18. Philip S. Wang

Corresponding author

Correspondence to Jason B. Gibbons.

Ethics declarations

Competing interests

Jason B. Gibbons has a financial interest in Adaptive Testing Technologies, a company that develops online mental and behavioral health assessment tools. Dr. Gibbons’ interests were reviewed and are managed by BWH and Mass General Brigham in accordance with their conflict-of-interest policies. All other authors declare no competing financial or nonfinancial interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gibbons, J.B., Leenaerts, N., Siddiqi, S.H. et al. Reinforcement learning for repetitive transcranial magnetic stimulation protocol selection in treatment-resistant depression. npj Digit. Med. (2026). https://doi.org/10.1038/s41746-026-03417-4

Download citation

  • Received: 04 June 2026

  • Accepted: 05 October 2026

  • Published: 19 October 2026

  • DOI: https://doi.org/10.1038/s41746-026-03417-4

来源:Nature 健康护理主题 · nature.com